Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Where the Presidential Candidates Stand on Key Healthcare Issues

Michael O'Neal  |  Issue: August 2012  |  August 8, 2012

Romney takes a specific stance on stem-cell research and therapy, citing that, although he believes stem-cell therapy can benefit patients (his wife, for example, who has multiple sclerosis), only preexisting embryos that are left over from in vitro fertilizations should be used to develop stem-cell treatments. Romney believes that no new embryos should be fertilized for the sole purpose of harvesting stem cells for treating patients.

Information Technology

At this point, Romney’s views on health information technology are vague. A report by the American College of Physicians (ACP) published on May 3, 2012, that examined the presidential candidates’ views, states that, “Romney supports efforts to facilitate information technology interoperability.” This statement is at odds with Romney’s promise to repeal ACA in its entirety because the law contains specific provisions for increasing use of health information systems and implementation incentives for practices. While most political experts agree that a full “repeal and replace” of the ACA is unlikely, it remains to be seen which pieces of the ACA Romney might reinstall after the repeal he has promised if he is elected president and if he has a Republican-controlled Congress to support him.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Both Candidates

Tier IV Co-pays

On March 19, the bipartisan Patients’ Access to Treatments Act of 2012 was introduced by Rep. David McKinley (R-WV) and Rep. Lois Capps (D-CA), along with other cosponsors. The Act would increase the ability of patients to access medically necessary specialty drugs, like biologics used to treat RA. It would do this by limiting commercial insurance plans’ cost-sharing requirements for specialty drugs (usually placed in Tier IV) to the dollar amount of cost sharing the plans require for preferred-brand drugs (typically placed in Tier III). The ACR is working with the Arthritis Foundation on companion legislation in the Senate and garnering cosponsors for the House version. They are also bringing other physician and patient organizations into a broad coalition in support of these initiatives. There have been no formal comments from either candidate about the introduction of this Act.

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Michael O’Neal is a writer based in New Jersey.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)drugLegislationMedicaidMedicareObamaResearchrheumatologistSGRTechnology

Related Articles

    What the Affordable Care Act Means for Rheumatology

    January 1, 2014

    Expected to flood the healthcare system with an influx of insured patients, Obamacare will likely exacerbate physician shortages, worsen capacity issues for many rheumatologists, and pressure providers to deliver a measurable quality of care, but analysts say rheumatology patients will benefit from expanded insurance coverage options

    President’s Perspective: ACR Addresses Reform of Sustainable Growth Rate Formula

    December 1, 2013

    The College’s multi-pronged plan to replace flawed SGR payment system requires continued support from rheumatologists, healthcare professionals

    Rheumatologists React to Looming Medicare Payment Reductions

    November 1, 2011

    MedPAC recommends deep cuts to physician payments

    A Fork in the Road: Advocacy for Rheumatology

    July 10, 2012

    Is that fork bent? So you must be a rheumatologist.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences